The global AI Medical Imaging Software for Lung Diseases market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

AI medical imaging software for lung diseases leverages artificial intelligence to automatically analyze medical images such as CT scans and X-rays, assisting physicians in detecting and diagnosing various lung conditions, including lung nodules, pneumonia, and chronic obstructive pulmonary disease (COPD). The software utilizes deep learning algorithms to identify abnormalities and offers precise localization and classification suggestions, enhancing diagnostic accuracy and efficiency. It also supports early disease detection and aids in clinical decision-making, reducing the workload on healthcare professionals.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

AI Medical Imaging Software for Lung Diseases leading manufacturers including Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, United-Imaging, Yizhun Intelligent, VoxelCloud, Fosun Aitrox, Huiying Medical, etc., dominate supply; the top five capture approximately % of global revenue, with Siemens leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI Medical Imaging Software for Lung Diseases market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of AI Medical Imaging Software for Lung Diseases Market Report

Report Metric	Details
Report Name	AI Medical Imaging Software for Lung Diseases Market
Segment by Type	Pulmonary Nodules Pneumonia Other
Segment by Application	Hospital Clinic
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, United-Imaging, Yizhun Intelligent, VoxelCloud, Fosun Aitrox, Huiying Medical, BioMind
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the AI Medical Imaging Software for Lung Diseases study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the AI Medical Imaging Software for Lung Diseases Market report?

Ans: The main players in the AI Medical Imaging Software for Lung Diseases Market are Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, United-Imaging, Yizhun Intelligent, VoxelCloud, Fosun Aitrox, Huiying Medical, BioMind

What are the Application segmentation covered in the AI Medical Imaging Software for Lung Diseases Market report?

Ans: The Applications covered in the AI Medical Imaging Software for Lung Diseases Market report are Hospital, Clinic

What are the Type segmentation covered in the AI Medical Imaging Software for Lung Diseases Market report?

Ans: The Types covered in the AI Medical Imaging Software for Lung Diseases Market report are Pulmonary Nodules, Pneumonia, Other

1 Study Coverage

1.1 Introduction to AI Medical Imaging Software for Lung Diseases: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Pulmonary Nodules

1.2.3 Pneumonia

1.2.4 Other

1.3 Market Segmentation by Application

1.3.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global AI Medical Imaging Software for Lung Diseases Revenue Estimates and Forecasts 2020-2031

2.2 Global AI Medical Imaging Software for Lung Diseases Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global AI Medical Imaging Software for Lung Diseases Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global AI Medical Imaging Software for Lung Diseases Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Pulmonary Nodules Market Size by Players

3.3.2 Pneumonia Market Size by Players

3.3.3 Other Market Size by Players

3.4 Global AI Medical Imaging Software for Lung Diseases Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global AI Medical Imaging Software for Lung Diseases Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)

6.4 North America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America AI Medical Imaging Software for Lung Diseases Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)

7.4 Europe AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)

8.4 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)

9.4 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America AI Medical Imaging Software for Lung Diseases Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Type (2020-2031)

10.4 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa AI Medical Imaging Software for Lung Diseases Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Siemens

11.1.1 Siemens Corporation Information

11.1.2 Siemens Business Overview

11.1.3 Siemens AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.1.4 Siemens AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.1.5 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024

11.1.6 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024

11.1.7 Siemens AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024

11.1.8 Siemens AI Medical Imaging Software for Lung Diseases SWOT Analysis

11.1.9 Siemens Recent Developments

11.2 Riverain Technologies

11.2.1 Riverain Technologies Corporation Information

11.2.2 Riverain Technologies Business Overview

11.2.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.2.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.2.5 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024

11.2.6 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024

11.2.7 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024

11.2.8 Riverain Technologies AI Medical Imaging Software for Lung Diseases SWOT Analysis

11.2.9 Riverain Technologies Recent Developments

11.3 Deepwise

11.3.1 Deepwise Corporation Information

11.3.2 Deepwise Business Overview

11.3.3 Deepwise AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.3.4 Deepwise AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.3.5 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024

11.3.6 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024

11.3.7 Deepwise AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024

11.3.8 Deepwise AI Medical Imaging Software for Lung Diseases SWOT Analysis

11.3.9 Deepwise Recent Developments

11.4 Shukun Technology

11.4.1 Shukun Technology Corporation Information

11.4.2 Shukun Technology Business Overview

11.4.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.4.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.4.5 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024

11.4.6 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024

11.4.7 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024

11.4.8 Shukun Technology AI Medical Imaging Software for Lung Diseases SWOT Analysis

11.4.9 Shukun Technology Recent Developments

11.5 Infervision Medical

11.5.1 Infervision Medical Corporation Information

11.5.2 Infervision Medical Business Overview

11.5.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.5.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.5.5 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Product in 2024

11.5.6 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Application in 2024

11.5.7 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue by Geographic Area in 2024

11.5.8 Infervision Medical AI Medical Imaging Software for Lung Diseases SWOT Analysis

11.5.9 Infervision Medical Recent Developments

11.6 United-Imaging

11.6.1 United-Imaging Corporation Information

11.6.2 United-Imaging Business Overview

11.6.3 United-Imaging AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.6.4 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.6.5 United-Imaging Recent Developments

11.7 Yizhun Intelligent

11.7.1 Yizhun Intelligent Corporation Information

11.7.2 Yizhun Intelligent Business Overview

11.7.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.7.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.7.5 Yizhun Intelligent Recent Developments

11.8 VoxelCloud

11.8.1 VoxelCloud Corporation Information

11.8.2 VoxelCloud Business Overview

11.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.8.5 VoxelCloud Recent Developments

11.9 Fosun Aitrox

11.9.1 Fosun Aitrox Corporation Information

11.9.2 Fosun Aitrox Business Overview

11.9.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.9.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.9.5 Fosun Aitrox Recent Developments

11.10 Huiying Medical

11.10.1 Huiying Medical Corporation Information

11.10.2 Huiying Medical Business Overview

11.10.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.10.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 BioMind

11.11.1 BioMind Corporation Information

11.11.2 BioMind Business Overview

11.11.3 BioMind AI Medical Imaging Software for Lung Diseases Product Features and Attributes

11.11.4 BioMind AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2020-2025)

11.11.5 BioMind Recent Developments

12 AI Medical Imaging Software for Lung DiseasesIndustry Chain Analysis

12.1 AI Medical Imaging Software for Lung Diseases Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 AI Medical Imaging Software for Lung Diseases Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global AI Medical Imaging Software for Lung Diseases Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Siemens AG

Riverain Technologies

List of Tables

Table 1. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global AI Medical Imaging Software for Lung Diseases Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global AI Medical Imaging Software for Lung Diseases Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global AI Medical Imaging Software for Lung Diseases Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global AI Medical Imaging Software for Lung Diseases by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Medical Imaging Software for Lung Diseases as of 2024)

Table 11. Global AI Medical Imaging Software for Lung Diseases Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global AI Medical Imaging Software for Lung Diseases Companies Headquarters

Table 13. Global AI Medical Imaging Software for Lung Diseases Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2026-2031) & (US$ Million)

Table 21. AI Medical Imaging Software for Lung Diseases High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers

Table 25. North America AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers

Table 27. Europe AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific AI Medical Imaging Software for Lung Diseases Growth Accelerators and Market Barriers

Table 29. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America AI Medical Imaging Software for Lung Diseases Investment Opportunities and Key Challenges

Table 31. Central and South America AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa AI Medical Imaging Software for Lung Diseases Investment Opportunities and Key Challenges

Table 33. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Siemens Corporation Information

Table 35. Siemens Description and Major Businesses

Table 36. Siemens Product Features and Attributes

Table 37. Siemens Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Siemens Revenue Proportion by Product in 2024

Table 39. Siemens Revenue Proportion by Application in 2024

Table 40. Siemens Revenue Proportion by Geographic Area in 2024

Table 41. Siemens AI Medical Imaging Software for Lung Diseases SWOT Analysis

Table 42. Siemens Recent Developments

Table 43. Riverain Technologies Corporation Information

Table 44. Riverain Technologies Description and Major Businesses

Table 45. Riverain Technologies Product Features and Attributes

Table 46. Riverain Technologies Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Riverain Technologies Revenue Proportion by Product in 2024

Table 48. Riverain Technologies Revenue Proportion by Application in 2024

Table 49. Riverain Technologies Revenue Proportion by Geographic Area in 2024

Table 50. Riverain Technologies AI Medical Imaging Software for Lung Diseases SWOT Analysis

Table 51. Riverain Technologies Recent Developments

Table 52. Deepwise Corporation Information

Table 53. Deepwise Description and Major Businesses

Table 54. Deepwise Product Features and Attributes

Table 55. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Deepwise Revenue Proportion by Product in 2024

Table 57. Deepwise Revenue Proportion by Application in 2024

Table 58. Deepwise Revenue Proportion by Geographic Area in 2024

Table 59. Deepwise AI Medical Imaging Software for Lung Diseases SWOT Analysis

Table 60. Deepwise Recent Developments

Table 61. Shukun Technology Corporation Information

Table 62. Shukun Technology Description and Major Businesses

Table 63. Shukun Technology Product Features and Attributes

Table 64. Shukun Technology Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Shukun Technology Revenue Proportion by Product in 2024

Table 66. Shukun Technology Revenue Proportion by Application in 2024

Table 67. Shukun Technology Revenue Proportion by Geographic Area in 2024

Table 68. Shukun Technology AI Medical Imaging Software for Lung Diseases SWOT Analysis

Table 69. Shukun Technology Recent Developments

Table 70. Infervision Medical Corporation Information

Table 71. Infervision Medical Description and Major Businesses

Table 72. Infervision Medical Product Features and Attributes

Table 73. Infervision Medical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Infervision Medical Revenue Proportion by Product in 2024

Table 75. Infervision Medical Revenue Proportion by Application in 2024

Table 76. Infervision Medical Revenue Proportion by Geographic Area in 2024

Table 77. Infervision Medical AI Medical Imaging Software for Lung Diseases SWOT Analysis

Table 78. Infervision Medical Recent Developments

Table 79. United-Imaging Corporation Information

Table 80. United-Imaging Description and Major Businesses

Table 81. United-Imaging Product Features and Attributes

Table 82. United-Imaging Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. United-Imaging Recent Developments

Table 84. Yizhun Intelligent Corporation Information

Table 85. Yizhun Intelligent Description and Major Businesses

Table 86. Yizhun Intelligent Product Features and Attributes

Table 87. Yizhun Intelligent Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Yizhun Intelligent Recent Developments

Table 89. VoxelCloud Corporation Information

Table 90. VoxelCloud Description and Major Businesses

Table 91. VoxelCloud Product Features and Attributes

Table 92. VoxelCloud Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. VoxelCloud Recent Developments

Table 94. Fosun Aitrox Corporation Information

Table 95. Fosun Aitrox Description and Major Businesses

Table 96. Fosun Aitrox Product Features and Attributes

Table 97. Fosun Aitrox Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Fosun Aitrox Recent Developments

Table 99. Huiying Medical Corporation Information

Table 100. Huiying Medical Description and Major Businesses

Table 101. Huiying Medical Product Features and Attributes

Table 102. Huiying Medical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Huiying Medical Recent Developments

Table 104. BioMind Corporation Information

Table 105. BioMind Description and Major Businesses

Table 106. BioMind Product Features and Attributes

Table 107. BioMind Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. BioMind Recent Developments

Table 109. Raw Materials Key Suppliers

Table 110. Distributors List

Table 111. Market Trends and Market Evolution

Table 112. Market Drivers and Opportunities

Table 113. Market Challenges, Risks, and Restraints

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. AI Medical Imaging Software for Lung Diseases Product Picture

Figure 2. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Pulmonary Nodules Product Picture

Figure 4. Pneumonia Product Picture

Figure 5. Other Product Picture

Figure 6. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Hospital

Figure 8. Clinic

Figure 9. AI Medical Imaging Software for Lung Diseases Report Years Considered

Figure 10. Global AI Medical Imaging Software for Lung Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 12. Global AI Medical Imaging Software for Lung Diseases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Region (2020-2031)

Figure 14. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share Ranking (2024)

Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 16. Pulmonary Nodules Revenue Market Share by Player in 2024

Figure 17. Pneumonia Revenue Market Share by Player in 2024

Figure 18. Other Revenue Market Share by Player in 2024

Figure 19. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2020-2031)

Figure 20. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2020-2031)

Figure 21. North America AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)

Figure 22. North America Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024

Figure 23. North America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020 - 2031)

Figure 24. North America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)

Figure 25. US AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 26. Canada AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 27. Mexico AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 28. Europe AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)

Figure 29. Europe Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024

Figure 30. Europe AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)

Figure 31. Europe AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)

Figure 32. Germany AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 33. France AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 34. U.K. AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 35. Italy AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 36. Russia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Top 8 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024

Figure 39. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)

Figure 40. Asia-Pacific AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)

Figure 41. Indonesia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 42. Japan AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 43. South Korea AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 44. Australia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 45. India AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 46. Indonesia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 47. Vietnam AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 48. Malaysia AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 49. Philippines AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 50. Singapore AI Medical Imaging Software for Lung Diseases Revenue (2020-2031) & (US$ Million)

Figure 51. Central and South America AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)

Figure 52. Central and South America Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024

Figure 53. Central and South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)

Figure 54. Central and South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)

Figure 55. Brazil AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)

Figure 56. Argentina AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)

Figure 57. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue YoY (2020-2031) & (US$ Million)

Figure 58. Middle East and Africa Top 5 Players AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) in 2024

Figure 59. South America AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Type (2020-2031)

Figure 60. Middle East and Africa AI Medical Imaging Software for Lung Diseases Revenue (US$ Million) by Application (2020-2031)

Figure 61. GCC Countries AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)

Figure 62. Israel AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)

Figure 63. Egypt AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)

Figure 64. South Africa AI Medical Imaging Software for Lung Diseases Revenue (2020-2025) & (US$ Million)

Figure 65. AI Medical Imaging Software for Lung Diseases Industry Chain Mapping

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37F12574

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J20209

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8O12834

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36J12622

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions